Education
About Us
Working with TipRanks
Follow Us
ProKidney (PROK)
NASDAQ:PROK
Total Valuation
ProKidney has a market cap or net worth of $662.14M. The enterprise value is $1.13B.
Market Cap$662.14M
Enterprise Value$1.13B
Share Statistics
ProKidney has 134,993,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding134,993,530
Owned by Insiders82.51%
Owned by Institutions0.05%
Financial Efficiency
ProKidney’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is -45.03%.
Return on Equity (ROE)0.06
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-45.03%
Return on Capital Employed (ROCE)-0.45
Revenue Per Employee372.55
Profits Per Employee-800.66K
Employee Count204
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ProKidney is ―. ProKidney’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value-0.17
Price to FCF―
Price to Operating Cash Flow-2.09
PEG Ratio―
Income Statement
In the last 12 months, ProKidney had revenue of 76.00K and earned -61.19M in profits. Earnings per share was -0.62.
Revenue76.00K
Gross Profit76.00K
Operating Income-183.68M
Pretax Income-163.93M
Net Income-61.19M
EBITDA-158.49M
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was -143.62M and capital expenditures -29.05M, giving a free cash flow of -172.67M billion.
Operating Cash Flow-143.62M
Free Cash Flow-172.67M
Free Cash Flow per Share-1.28
Dividends & Yields
ProKidney pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.21
52-Week Price Change-5.86%
50-Day Moving Average2.58
200-Day Moving Average1.57
Relative Strength Index (RSI)43.80
Average Volume (3m)2.16M
Important Dates
ProKidney upcoming earnings date is Nov 18, 2025, After Close (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
ProKidney as a current ratio of 10.93, with Debt / Equity ratio of 1.04%
Current Ratio10.93
Quick Ratio10.93
Debt to Market Cap<0.01
Net Debt to EBITDA0.60
Interest Coverage Ratio-20.41K
Taxes
In the past 12 months, ProKidney has paid -598.00K in taxes.
Income Tax-598.00K
Effective Tax Rate<0.01
Enterprise Valuation
ProKidney EV to EBITDA ratio is -1.76, with an EV/FCF ratio of -1.79.
EV to Sales3.68K
EV to EBITDA-1.76
EV to Free Cash Flow-1.79
EV to Operating Cash Flow-2.21
Balance Sheet
ProKidney has $294.73M in cash and marketable securities with $3.52M in debt, giving a net cash position of -$291.21M billion.
Cash & Marketable Securities$294.73M
Total Debt$3.52M
Net Cash-$291.21M
Net Cash Per Share-$2.16
Tangible Book Value Per Share$4.10
Margins
Gross margin is -127.51%, with operating margin of -241678.95%, and net profit margin of -80507.89%.
Gross Margin-127.51%
Operating Margin-241678.95%
Pretax Margin-215701.32%
Net Profit Margin-80507.89%
EBITDA Margin-208542.11%
EBIT Margin-215689.47%
Analyst Forecast
The average price target for ProKidney is $5.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.80
Price Target Upside157.78% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast4.97%